[EN] INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS<br/>[FR] INHIBITEURS DE L'INTERACTION DES RÉCEPTEURS UPAR/FPRS
申请人:ORPHA BIOTECH S R L
公开号:WO2021198844A1
公开(公告)日:2021-10-07
Compound of formula (I) wherein R1 is selected from the group consisting of: H, Me, OH; R2 is selected from the group consisting of: H, OH, Me, t-Bu, Et, OMe, Pr, Allyl; R3 is selected from the group consisting of: H, OH, Me, Cl, F; R4 is selected from the group consisting of: H, Me, Ome, t-Bu, Cl; R5 is selected from the group consisting of: H, OH, Me, OMe; R6 is selected from the group consisting of: H, Me, OH, OMe; R7 is selected from the group consisting of: H, Me, OMe, t-Bu, Cl; R8 is selected from the group consisting of: OH, Me, H, F; R9 is selected from the group consisting of; OH, Me, H, t-Bu, Et, OMe, Pr, Allyl; R10 is selected from the group consisting of: H, Me, OH; and X is either absent or is selected from the group consisting of: Formula (II), CO, CH2, Formula (III) for use in a method for treating pathologies mediated by the interaction of the uPAR/FPRs receptors.